Fei Su
Impact in
-
- Immunotherapy and Immune Responses
-
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
Papers in
-
- CRISPR and Genetic Engineering 3
- Surgery 6
- Co-authors
- Wangxue Chen (1 shared paper)G. B. Patel (1 shared paper)Songhua Hu (1 shared paper)Joseph L. Witztum (1 shared paper)Shuting Xia (2 shared papers)Sotirios Tsimikas (2 shared papers)Calvin Yeang (2 shared papers)Ewa Karwatowska‐Prokopczuk (1 shared paper)
- Journals
- Journal of the American College of Cardiology (2 papers)Medicine (2 papers)Vaccines (2 papers)PeerJ (1 paper)mBio (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Fei Su
38 papers receiving 700 citations
Fei Su's Hit Papers
Peers
Comparison fields: 5 of 97
- Immunology 117
- Infectious Diseases 81
- Ophthalmology 36
- Molecular Biology 230
- Microbiology 20
Countries citing papers authored by Fei Su
This map shows the geographic impact of Fei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Su more than expected).
Fields of papers citing papers by Fei Su
This network shows the impact of papers produced by Fei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Su. The network helps show where Fei Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol Hit paper breakdown → | 2022 | 139 |
| 2 | 2016 | 114 | |
| 3 | 2019 | 46 | |
| 4 | 2018 | 45 | |
| 5 | 2023 | 44 | |
| 6 | 2021 | 30 | |
| 7 | 2023 | 27 | |
| 8 | 2019 | 27 | |
| 9 | 2021 | 22 | |
| 10 | 2020 | 19 | |
| 11 | 2017 | 18 | |
| 12 | 2021 | 17 | |
| 13 | 2021 | 14 | |
| 14 | 2011 | 12 | |
| 15 | 2022 | 12 | |
| 16 | 2019 | 11 | |
| 17 | 2023 | 11 | |
| 18 | 2019 | 10 | |
| 19 | 2017 | 10 | |
| 20 | 2023 | 8 |
About Fei Su
Fei Su is a scholar working on Molecular Biology, Surgery, Infectious Diseases, Epidemiology and Immunology, having authored 39 papers that have together received 710 indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (5 papers), Animal Virus Infections Studies (4 papers), Herpesvirus Infections and Treatments (3 papers), Immune Response and Inflammation (3 papers), Cerebrovascular and genetic disorders (3 papers), CRISPR and Genetic Engineering (3 papers), Antibiotic Resistance in Bacteria (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Immunology (117 citations), Infectious Diseases (81 citations), Ophthalmology (36 citations), Molecular Biology (230 citations) and Microbiology (20 citations). Fei Su has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Wangxue Chen, G. B. Patel, Songhua Hu, Joseph L. Witztum, Shuting Xia, Sotirios Tsimikas, Calvin Yeang, Ewa Karwatowska‐Prokopczuk, Liuqing Chen and Yun Xia. Their work appears in journals such as Journal of the American College of Cardiology, Medicine, Vaccines, PeerJ and mBio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.